BIOMAT Database Logo BIOMAT Database Logo

Opioid peptide receptor studies. 9. Identification of a novel non-mu- non-delta-like opioid peptide binding site in rat brain. 1998

Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Clinical Psychopharmacology Section, DIR, NIDA, NIH, Baltimore, MD 21224, USA.

Quantitative binding studies resolved two high-affinity [3H][D-Ala2,D-Leu5]enkephalin binding sites in rat brain membranes depleted of mu binding sites by pretreatment with the irreversible agent BIT. The two binding sites had lower (delta ncx-2, Ki = 96.6 nM) and higher (delta ncx-1, Ki = 1.55 nM) affinity for DPDPE. The ligand-selectivity profile of the delta ncx-1 site was that of a classic delta binding site. The ligand-selectivity profile of the delta ncx-2 site was neither mu- or delta-like. The Ki values of selected agents for the delta ncx-2 site were: [pCl]DPDPE (3.9 nM), DPLPE (140 nM), and DAMGO (2.6 nM). Under these assay conditions, [3H][D-Ala2,D-Leu5]enkephalin binding to the cells expressing the cloned mu receptor is very low and pretreatment of cell membranes with BIT almost completely inhibits [3H]DAMGO and [3H][D-Ala2,D-Leu5]enkephalin binding. Intracerebroventricular administration of antisense DNA to the cloned delta receptor selectively decreased [3H][D-Ala2,D-Leu5]enkephalin binding to the delta ncx-1 site. Administration of buprenorphine to rats 24 h prior to preparation of membranes differentially affected mu, delta ncx-1, and delta ncx-2 binding sites. Viewed collectively, these studies have identified a novel non-mu- non-delta-like binding site in rat brain.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002047 Buprenorphine A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. 6029-M,Buprenex,Buprenorphine Hydrochloride,Buprex,Prefin,RX-6029-M,Subutex,Temgesic,Temgésic,6029 M,6029M,Hydrochloride, Buprenorphine,RX 6029 M,RX6029M
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D000701 Analgesics, Opioid Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. Opioid,Opioid Analgesic,Opioid Analgesics,Opioids,Full Opioid Agonists,Opioid Full Agonists,Opioid Mixed Agonist-Antagonists,Opioid Partial Agonists,Partial Opioid Agonists,Agonist-Antagonists, Opioid Mixed,Agonists, Full Opioid,Agonists, Opioid Full,Agonists, Opioid Partial,Agonists, Partial Opioid,Analgesic, Opioid,Full Agonists, Opioid,Mixed Agonist-Antagonists, Opioid,Opioid Agonists, Full,Opioid Agonists, Partial,Opioid Mixed Agonist Antagonists,Partial Agonists, Opioid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D016308 Enkephalin, Leucine-2-Alanine A delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate. 2-Alanyl-Leucine Enkephalin,5-Leucine-2-Alanine Enkephalin,D-Ala(2)-D-Leu(5)-Enkephalin,Enkephalin-Leu,Ala(2),Leucine Enkephalin-2-Alanine,BW-180C,DADLE,Leu-Enkephalin-2-Ala,2 Alanyl Leucine Enkephalin,5 Leucine 2 Alanine Enkephalin,BW 180C,BW180C,Enkephalin, 2-Alanyl-Leucine,Enkephalin, 5-Leucine-2-Alanine,Enkephalin, Leucine 2 Alanine,Enkephalin-2-Alanine, Leucine,Leu Enkephalin 2 Ala,Leucine Enkephalin 2 Alanine,Leucine-2-Alanine Enkephalin

Related Publications

Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Opioid peptide receptor studies. 1. Identification of a novel delta-opioid receptor binding site in rat brain membranes.
January 1995, Peptides,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Identification of distinct binding site subunits of mu and delta opioid receptors.
January 1986, Biochemistry,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTP gamma S binding in rat brain.
February 1996, Neuroreport,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Identification of an opioid receptor subunit carrying the mu binding site.
November 1984, Biochemistry,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
December 1986, Brain research,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
April 1999, Synapse (New York, N.Y.),
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
March 1987, The Journal of pharmacology and experimental therapeutics,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors.
August 2008, Peptides,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Differential ontogeny of divalent cation effects on rat brain delta-, mu-, and kappa-opioid receptor binding.
February 1987, Brain research,
Q Ni, and H Xu, and J S Partilla, and K C Rice, and D Matecka, and S N Calderon, and F Porreca, and J Lai, and H Schmidhammer, and R Krassnig, and R B Rothman
Ontogenetic studies on mu, delta and kappa opioid receptors in rat brain.
October 1986, Pharmacological research communications,
Copied contents to your clipboard!